Gene test could save men from prostate surgery

Doctors have developed a technique that could save thousands of men from impotence by predicting how aggressive Prostate cancer is before surgery.

At present needle biopsies, blood and urine samples are unable to predict accurately how dangerous prostate cancer is and whether it is likely to progress.

This means that thousands of men may be having unnecessary preventive surgery, with serious side effects such as impotence.

Now a study, published in the British Journal of Cancer, has outlined a simple and reliable technique which can be carried out on needle biopsy samples.

The Checkerboard Tissue Microarray (TMA) method, developed by scientists at the Institute of Cancer Research, looks for the multiple markers of various genes associated with Prostate cancer - including the E2F3 gene. “Overexpression” of E2F3 - first identified by the institute - is a marker of how aggressive cancer will be.

Prostate cancer is the most common cancer to affect men in the UK, with more than 30,000 diagnosed every year. Almost 10,000 men die from the disease each year.

Researchers said the new technique would allow them to investigate an enormous untapped resource of clinical specimens which were obtained at the time of cancer diagnosis.

This would allow them to identify markers of the cancer’s aggressiveness.

The tissues in the prostate gland, an organ at the base of the bladder in men, are either surgically removed or destroyed through radiotherapy as a way to treat the cancer. This radical surgery can have serious side effects such as incontinence and impotence.

Professor Colin Cooper, the Grand Charity of Freemasons’ Chair of Molecular Biology at the institute, hopes to have a reliable test in place within two years.

He said: “This represents a real advance for the future management of Prostate cancer.

“Eventually we hope to be able to distinguish the tigers - aggressive tumours requiring treatment - from the pussycats - non-aggressive tumours which can be monitored for many years without treatment.

“Ultimately this could prevent thousands of men from having to undergo radical surgery, which can have devastating effects on their day-to-day lives.”

Professor Peter Rigby, chief executive of the institute, said: “This demonstrates the real progress we are making in the field of Prostate cancer research.

“Since discovering the E2F3 gene as a marker of Prostate cancer aggressiveness our research team has been committed to developing a test for the gene. The development of this technique is a significant step forward in Prostate cancer management and should ultimately improve thousands of men’s lives.”

Dr Chris Hiley, head of policy and research at the Prostate Cancer Charity, welcomed the development.

He said: “The difficulty that confronts many men and their doctors is in establishing whether a man’s Prostate cancer will be so slow-growing that he may not need treatment or whether it is potentially life threatening and he does.

“If the technique is proven, it will identify these [genetic] markers across a huge number of samples and will enable doctors to predict the behaviour of individual Prostate cancers, so that men will receive the most appropriate treatment.”

RELATED STORIES:
Complementary Alternative Medical (CAM) Therapy and Prostate Cancer   Obese men less likely to get biopsy after PSA screening   Counseling helps sex life after prostate cancer   Childless men run lower risk of prostate cancer   Study Drug Holds Promise As Alternative to Castration For Early Prostate Cancers   Higher doses of radiation for prostate cancer do not decrease sexual function   Hormonal Dietary Supplements Might Promote Prostate Cancer Progression   Early prostate cancer detection, screening: No benefit for men with low baseline PSA value   Vitamin E may raise prostate cancer risk   Prostate cancer vaccine improves survival   Trimodal approach to prostate cancer promising   Green Tea May Affect Prostate Cancer Progression   Scientists see progress in prostate cancer tests   Gene Fusion Discovery May Lead to Improved Prostate Cancer Test   First Biomarker Discovered that Predicts Prostate Cancer Outcome   Many Elderly Men Are Undergoing Unnecessary PSA Screenings   Prostate cancer treatment choices vary based on type of specialist consulted   Smaller prostate size, more aggressive cancer   Prostate Cancer - Patterns of Progression   Can Changing Your Lifestyle Help Treat Prostate Cancer?   Prostate test ‘public health disaster’ - discoverer   Researchers Studying Novel Therapy For Prostate Cancer

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]